Jeffrey T Borenstein

This inventor holds 91 USPTO granted patents and 20 published patent applications, plus 6 CIPO patents and 23 EPO patents, primarily in Microfluidic Devices (CPC class B01D63-088). Top assignees: The Charles Stark Draper Laboratory, Inc., The General Hospital Corporation, Massachusetts Institute of Technology. Active years: 1991-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffrey T Borenstein. Retrieved from https://idiyas.com/inventor/jeffrey-t-borenstein

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 91 (Patent Applications = 20)

% Patents Active = 91.2

CIPO Patents = 6 (Patent Applications = 3)

EPO Patents = 23 (Patent Applications = 27)

Average Co-Inventor Count = 4.3

ph-index = 19

Forward Citations = 1,156(Granted Patents)

Forward Citations (Not Self Cited) = 1,044(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Burlington, MA (US) (1991)
Maynard, MA (US) (1993)
Belmont, MA (US) (2001 - 2003)
Hollison, MA (US) (2004)
Cambridge, MA (US) (2008)
Hilliston, MA (US) (2009)
Newton Upper Falls, MA (US) (2016 - 2018)
Holliston, MA (US) (2004 - 2023)
Newton, MA (US) (2010 - 2023)

Company Filing History:

82 out of 1,156

The Charles Stark Draper Laboratory, Inc.

patents

19 out of 3,080

The General Hospital Corporation

patents

14 out of 8,608

Massachusetts Institute of Technology

patents

4. 5 out of 1,430

The Brigham and Women's Hospital, Inc.

patents

5. 4 out of 277

Massachusetts Eye and Ear Infirmary

patents

6. 2 out of 47

Mobil Solar Energy Corporation

patents

7. 1 out of 1,077

Children's Medical Center Corporation

patents

8. 1 out of 1

Johnson & Johnson Innovation LLC

10. 2 out of 834,659

Other

patents

where one patent can have more than one assignee

Years Active: 1991-2026

Loading Chart...

Areas of Expertise:

Microfluidic Cell Culture

Tumor-Immune Microenvironment

Drug Delivery

Biomimetic Devices

Genetic Modification

Tissue Biopsy

Vascularized Tissue

Electroporation

Cell Transduction

High-Throughput Testing

Biomedical Applications

Hydraulic Manifold

91 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12686843 - End-to-end cell therapy bioprocessing device for continuous-flow enrichment, washing, and electrotransfection of target cells (2026-07-21),

2. 12600931 - Microfluidic cell culture plate for air-liquid interface and 3D cultured tissue applications (2026-04-14),

3. 12440838 - Multiwell dynamic model for a tumor-immune microenvironment (2025-10-14),

4. 12247190 - Bi-layer multi-well cell culture platform (2025-03-11),

5. 12239808 - Hand tool for aiding in insertion of a trans-round window membrane catheter for micropump-mediated acute and chronic inner-ear drug delivery (2025-03-04),

6. 12208385 - Systems and methods for fabricating microfluidic devices (2025-01-28),

7. 12139697 - Apparatus for efficient genetic modification of cells (2024-11-12),

8. 11852626 - Microfluidic tissue biopsy and immune response drug evaluation devices and systems (2023-12-26),

9. 11673094 - Biomimetic microfluidic device for high efficiency carbon dioxide removal from patients at low blood flow rates (2023-06-13),

10. 11628437 - Microfluidic system for evaluation of chemotherapeutic and immunotherapeutic drugs (2023-04-18),

11. 11584908 - Apparatus for efficient genetic modification of cells (2023-02-21),

12. 11369722 - Systems and methods for increasing convective clearance of undesired particles in a microfluidic device (2022-06-28),

13. 11278885 - Systems and methods for fabricating microfluidic devices (2022-03-22),

14. 11261465 - Method and system for incorporation of biomolecules into vesicles, cells, and micelles using electroactive porous device membrane (2022-03-01),

15. 11022603 - Microfluidic tissue biopsy and immune response drug evaluation devices and systems (2021-06-01),

Title: Spotlight on Inventor Jeffrey T Borenstein: A Pioneer in Microfluidic Innovations

Introduction:

Jeffrey T Borenstein, a prolific inventor based in Newton, MA, has left an indelible mark on the field of microfluidics with his groundbreaking inventions. With an impressive 82 patents to his name, Borenstein's cutting-edge work has revolutionized the way we approach tissue biopsy and immune response drug evaluation.

Latest Patents:

Among his latest patents is the development of Microfluidic tissue biopsy and immune response drug evaluation devices and systems. This innovative technology utilizes microfluidic devices to capture tissue samples within a trapping region, allowing for precise analysis of fluid samples in contact with the tissue traps. Additionally, Borenstein has spearheaded the creation of a Biomimetic microfluidic device for high efficiency carbon dioxide removal from patients at low blood flow rates, providing a novel solution for patients with respiratory issues.

Career Highlights:

Having worked at esteemed institutions such as The Charles Stark Draper Laboratory, Inc. and The General Hospital Corporation, Borenstein has demonstrated a dedication to advancing healthcare technologies. His multidisciplinary expertise has paved the way for pioneering advancements in the medical field.

Collaborations:

Throughout his career, Jeffrey T Borenstein has collaborated with prominent colleagues such as Joseph L Charest and Joseph P Vacanti. Together, they have pushed the boundaries of microfluidic research, fostering a culture of innovation and excellence.

Conclusion:

In conclusion, Jeffrey T Borenstein stands as a trailblazer in the realm of microfluidic innovations, with his numerous patents and groundbreaking contributions shaping the future of healthcare technology. His relentless pursuit of excellence and collaborative spirit have solidified his legacy as a true visionary in the field.

Profile summary based on public USPTO records.